Forian Inc. (NASDAQ:FORA – Get Free Report) traded down 3.1% during trading on Wednesday . The stock traded as low as $1.87 and last traded at $1.87. 1,182 shares changed hands during trading, a decline of 93% from the average session volume of 16,762 shares. The stock had previously closed at $1.93.
Forian Price Performance
The stock has a fifty day simple moving average of $2.11 and a two-hundred day simple moving average of $2.13. The firm has a market capitalization of $58.33 million, a P/E ratio of -20.78 and a beta of 1.04.
Insider Activity
In other news, CEO Max C. Wygod purchased 12,320 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were acquired at an average price of $2.67 per share, for a total transaction of $32,894.40. Following the completion of the acquisition, the chief executive officer now owns 1,324,500 shares in the company, valued at approximately $3,536,415. The trade was a 0.94 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 31.30% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Forian
About Forian
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Recommended Stories
- Five stocks we like better than Forian
- What is Short Interest? How to Use It
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- What Does a Stock Split Mean?
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.